Richard Lopachin Memorial Fund supporting Band of Parents
Richard Lopachin Memorial Fund supporting Band of Parents
About In Memory of Richard Lopachin
Richard Lopachin, a neurotoxicologist who worked at Montefiore medical center for over 25 years, passed away on September 4th after a long battle with Alzheimer’s and Lewy body dementia. One of his major projects involved using novel drugs in order to prevent hearing loss from cisplatin, a chemotherapy drug commonly used in pediatric cancer therapy. While he has passed away, his important work continues today with the generous support from Band of Parents.
Date
Starts at: September 5, 2023 11:00 PM
Ends at: September 6, 2024 5:00 AM
Location
,
Contact
Here is a great spot to put the most important information about your campaign!
TIP: Did you know you can also add a pre-recorded or live stream video to this section? Just provide the full iframe code in the admin view under Configure Campaign > Design > Basic Design.
TIP: You can inline edit different areas to customize your campaign! Don't forget to save & refresh!
This project was one that he took a special pride in, and it was his hope that his work could help significantly reduce a terrible side effect of an otherwise lifesaving medication. His family would ask that you consider donating to not only help continue to fund this research, but many other projects aimed at helping to eradicate pediatric cancers.
How Your Support Makes a Difference
With your support, we can find a cure for neuroblastoma, while reducing the highly toxic nature of treatment.
Band of Parents' mission is to seek projects that have already been examined in the lab and are in need of assistance to rapidly move into a patient population. In the 1980s, fewer than 5% of children diagnosed with high risk neuroblastoma survived. Although today, most major medical centers have over a 50% survival rate, far too many children are still dying of this disease. The sad fact is that due to the high cost of research and the small number of children diagnosed annually, pediatric cancer is severely underfunded by both the pharmaceutical industry and the federal government. Less than 4% of the National Cancer Institute’s funding goes to fight pediatric cancer. We support our members through their children’s battle with neuroblastoma. Together, we are Bound by Hope that a cure is out there. We will continue this fight until not a single child is lost to this disease.